Amplius Wealth Advisors’s Eastman Chemical EMN Stock Holding History

Amplius Wealth Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19	Closed	-$2K	–	386
2021 Q4	$2K	Buy	+19	New	+$2.11K	﹤0.01%	829

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Amplius Wealth Advisors's EMN Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of Eastman Chemical (EMN) in Q1 2022, closing a stake of 19 shares — an estimated $2K sold.

Amplius Wealth Advisors first reported a position in EMN in Q4 2021 and held it in 1 quarter. The position peaked at $2K in Q4 2021. 751 funds tracked by Wall St. Rank hold EMN as of Q1 2022.

Amplius Wealth Advisors reported no remaining Eastman Chemical position as of Q1 2022 after selling out during the quarter.
Amplius Wealth Advisors sold 19 Eastman Chemical shares in Q1 2022, an estimated $2K.
Amplius Wealth Advisors first reported a position in Eastman Chemical in Q4 2021 and held it in 1 quarter.
Amplius Wealth Advisors's Eastman Chemical position peaked at $2K in Q4 2021.
751 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.